Compare Stocks

Enter up to five stock symbols separated by a comma or space (e.x BAC,WFC,JPM,LON:BARC).
 

 Emerald Health TherapeuticsKodiak SciencesSenesco TechnologiesBiotestMonash IVF Group
SymbolCVE:EMHNYSE:KODNYSE:ELOXETR:BIOASX:MVF
Price Information
Current PriceC$2.15$14.55$8.24€22.50A$1.44
52 Week RangeHoldBuyHoldHoldN/A
Analyst Ratings
Consensus RecommendationHoldBuyHoldHoldN/A
Consensus Price TargetC$4.20$19.1250N/A€24.10N/A
% Upside from Price Target95.35% upside31.44% upsideN/A7.11% upsideN/A
Trade Information
Market CapC$308.68 million$519.54 million$339.00 million$445.18 million$338.06 million
BetaN/AN/AN/AN/AN/A
Average Volume704,102115,71752,9661,927729,133
Sales & Book Value
Annual RevenueC$3.71 millionN/AN/A$389.80 million$150.86 million
Price / Sales83.31N/AN/A1.142.24
CashflowC$0.10 per shareN/AN/A€3.24 per shareA$0.02 per share
Price / Cash20.85N/AN/A6.9470.25
Book ValueC$1.19 per shareN/AN/A€16.46 per shareA$0.72 per share
Price / Book1.81N/AN/A1.371.98
Profitability
Net IncomeN/AN/AN/AN/AN/A
EPSC($0.20)N/AN/A€4.15A$0.08
Trailing P/E RatioN/A0.000.005.4217.72
Forward P/E Ratio
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/AN/AN/AN/AN/A
Return on Equity (ROE)N/AN/AN/AN/AN/A
Return on Assets (ROA)N/AN/AN/AN/AN/A
Dividend
Annual PayoutN/AN/AN/A€0.04A$0.06
Dividend YieldN/AN/AN/A0.18%4.18%
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/A0.96%74.07%
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio2.68%N/AN/A71.41%54.44%
Current Ratio0.79%N/AN/A4.42%0.76%
Quick Ratio0.55%N/AN/A2.05%0.42%
Ownership Information
Institutional Ownership PercentageN/AN/AN/AN/AN/A
Insider Ownership PercentageN/AN/AN/AN/AN/A
Miscellaneous
Employees113N/AN/A1,663588
Shares Outstanding143.57 million36.91 million36.03 million19.79 million235.58 million
Next Earnings DateN/A8/21/2019 (Estimated)8/7/2019 (Confirmed)N/AN/A
OptionableNot OptionableNot OptionableNot OptionableOptionableNot Optionable
 Emerald Health TherapeuticsKodiak SciencesSenesco TechnologiesBiotestMonash IVF Group

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel